Advertisement

Topics

Janssen Submits Application Seeking Approval of Sirukumab in United States for Rheumatoid Arthritis

11:11 EDT 23 Sep 2016 | Biotech-Finances

Friday, September 23rd 2016 at 12:00pm UTC HORSHAM, Pa.–(BUSINESS WIRE)– Janssen Biotech, Inc. (Janssen) announced today the submission of a Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) seeking approval of sirukumab for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). RA is a …

Cet article Janssen Submits Application Seeking Approval of Sirukumab in United
States for Rheumatoid Arthritis
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: Janssen Submits Application Seeking Approval of Sirukumab in United States for Rheumatoid Arthritis

NEXT ARTICLE

More From BioPortfolio on "Janssen Submits Application Seeking Approval of Sirukumab in United States for Rheumatoid Arthritis"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...